IDEAYA Biosciences, Inc. (IDYA) NASDAQ

27.87

-1.07(-3.70%)

Updated at June 02 04:00PM

Currency In USD

Valuation

Market Cap3.06B
Enterprise Value2.97B
P/E Ratio-17.65
PEG Ratio-0.4
Price/Sales Ratio10.87
Price/Book Ratio2.64
Enterprise/Revenue10.3
Enterprise/EBITDA-12.97

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-0.62
Operating Margin-0.81

Management Effectiveness

Return On Assets-0.14
Return On Equity-0.14

Income Statement

Revenue218.71M
Revenue/Share2.54
Gross Profit214.12M
EBITDA-154.72M
Net Income-113.7M
Diluted EPS-1.28

Balance Sheet

Total Cash671.2M
Total Cash/Share7.57
Total Debt28.6M
Total Debt/Equity0.03
Current Ratio10.74
Book Value Per Share10.57

Price History

52-Week Change31.34
52-Week High39.28
52-Week Low20.45
Moving Average 50 Days30.25
Moving Average 200 Days30.93

Statistics

Average Volume1.14M
Shares Outstanding87.86M
% Held by Institutions107.01

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A